Yes, when prescribed and monitored by a licensed medical provider
In addition to human studies, in DdY mice fed with high-fat diet animal models, yerba mat has been suggested to promote satiety through various mechanisms, including induction and/or enhancement of intestinal glucagon-like peptide-1 (GLP-1), modulation of serum leptin levels and a possible direct central satiety-stimulatory effect [61]
Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin
Other GLP-1 related products The GLP-1 space now includes everything from transdermal patches to oral drops to sublingual formulations
Desideri E, Ciccarone F, Ciriolo MR
Thats more than what weve seen with todays leading medications